PL BioScience
Latest round
- Series A
Last raised
- Apr 2024
Total raised
- $13M
Investors
- 9
About PL BioScience
Founded in 2015 and headquartered in Aachen, Germany, PL BioScience GmbH specializes in Human Platelet Lysate (HPL) products.PL BioScience GmbH specializes in the development and commercialization of Human Platelet Lysate (HPL) products under the brand name ELAREM™, which includes offerings such as ELAREM™ Prime, ELAREM™ Perform, and ELAREM™ Ultimate. These products are designed for academic research, diagnostics, and regenerative medicine, providing xeno-free alternatives to traditional cell culture supplements.The revenue model of PL BioScience centers on the direct sales of its ELAREM™ product line, including specialized Research Grade, GMP Grade, and GMP-Clinical Grade formulations. These products cater to specific safety and regulatory needs, with clients placing B2B orders based on their research requirements. The company is looking to target additional markets in Asia and North America by 2025, aiming to leverage its innovative HPL solutions in these regions.
Who invested in PL BioScience
9 investors across 2 rounds
See all investors in PL BioScience
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about PL BioScience
Who invested in PL BioScience?
PL BioScience has 9 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has PL BioScience raised?
PL BioScience has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did PL BioScience last raise money?
PL BioScience's most recent round on record is a Series A, in Apr 2024.
What does PL BioScience do?
Founded in 2015 and headquartered in Aachen, Germany, PL BioScience GmbH specializes in Human Platelet Lysate (HPL) products.
Where is PL BioScience headquartered?
PL BioScience is headquartered in Aachen, Germany.
Which VCs invest in companies like PL BioScience?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Highland Europe back biotechnology companies at PL BioScience's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like PL BioScience? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.